Macrophages are an important source of vascular endothelial growth factor (VEGF). Adenosine A 2A receptor (A 2A R) agonists with Toll-like receptor (TLR) 2, 4, 7, and 9 agonists synergistically induce macrophage VEGF expression. We show here using VEGF promoter-luciferase reporter constructs that the TLR4 agonist Escherichia coli lipopolysaccharide (LPS) and the A 2A R agonists NECA and CGS21680 synergistically augment VEGF transcription in macrophages and that the HRE in the VEGF promoter is essential for this transcription. We examined whether LPS and/or NECA induce HIF-1␣ expression. HIF-1␣ mRNA levels were increased in LPS-treated macrophages in an NF-B-dependent manner; NECA strongly increased these levels in an A 2A R-dependent manner. LPS induced luciferase expression from a HIF-1␣ promoter-luciferase construct in an A 2A R-independent manner. Further stimulation with NECA did not increase HIF-1␣ promoter activity, indicating that the A 2A R-dependent increase in HIF-1␣ mRNA is post-transcriptional. LPS/NECA treatment also increased HIF-1␣ protein and DNA binding levels. Deletion of putative NF-B-binding sites from the VEGF promoter did not affect LPS/NECA-induced VEGF promoter activity, suggesting that NF-B is not directly involved in VEGF transcription. Taken together, these data indicate that LPS/NECA-induced VEGF expression involves transcriptional regulation of the VEGF promoter by HIF-1␣ through the HRE. HIF-1␣ is transcriptionally induced by LPS and post-transcriptionally up-regulated in an A 2A R-dependent manner.
INTRODUCTIONMacrophages play a key role in induction of angiogenesis, which is crucial for wound healing, fibroproliferative responses, and solid tumor development (Crowther et al., 2001). When stimulated, macrophages secrete an array of cytokines and growth factors, including the potent angiogenic factor vascular endothelial growth factor (VEGF). VEGF is an endothelial cell-specific mitogen and plays an important role in vascular development and angiogenesis during embryogenesis, wound healing, solid tumor growth, and certain chronic fibroproliferative inflammatory diseases (Ferrara and Davis-Smyth, 1997). Macrophages are exquisitely sensitive to their microenvironment and produce VEGF in a tightly regulated manner (Crowther et al., 2001).Macrophages produce elevated levels of VEGF in response to a variety of stimuli, including hypoxia and endotoxin (lipopolysaccharide [LPS]) together with interferon-␥ (IFN-␥), and growth factors, and cytokines such as TGF-␣, TGF-, IL-1, and IL-6 (Goldman et al., 1993;Pertovaara et al., 1994;Levy et al., 1995;Cohen et al., 1996;Gille et al., 1997;Xiong et al., 1998). Other stimuli such as hydrogen peroxide and nitric oxide (NO) have also been implicated in VEGF up-regulation (Kimura et al., 2000;Cho et al., 2001). We have shown previously that VEGF expression by murine macrophages is synergistically up-regulated by Escherichia coli LPS acting through Toll-like receptor, TLR4, receptors with adenosine acting through A 2A receptors (A 2A Rs; Leibovich e...